HYFT
MindWalk Holdings Corp.
NASDAQ · Healthcare · Biotechnology · CA
$1.32
−0.75%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 15.5M | 15.3M | 24.5M | 24.5M | 20.7M |
| Cost of Revenue | 6.4M | 6.3M | 11.0M | 12.5M | 9.1M |
| Gross Profit | 9.1M | 9.0M | 13.5M | 12.1M | 11.6M |
| Operating Expenses | |||||
| R&D Expense | 5.0M | 4.9M | 4.9M | 4.0M | 14.1M |
| SG&A Expense | 18.9M | 18.9M | 19.0M | 19.1M | 19.0M |
| General & Admin Expense | 6.4M | — | 14.7M | 15.6M | 15.4M |
| Selling & Marketing Expense | 2.5M | — | 4.3M | 3.5M | 3.6M |
| Other Expenses | (18.0K) | — | 1.8M | 2.6M | 4.1M |
| Total Operating Expenses | 23.9M | 23.7M | 25.7M | 25.8M | 37.2M |
| Cost and Expenses | 30.3M | 30.0M | 36.7M | 38.3M | 46.3M |
| Operating Income (EBIT) | (14.8M) | (14.7M) | (12.2M) | (13.8M) | (25.6M) |
| Non-Operating | |||||
| Interest Income | 40.0K | — | — | 23.0K | 122.0K |
| Interest Expense | — | — | 9.9K | 19.0K | 30.0K |
| Net Interest Income | 40.0K | — | (9.9K) | 4.0K | 92.0K |
| Other Non-Op Income/Expense | (630.4K) | (605.6K) | (22.1M) | (14.9M) | (2.1M) |
| Non-Operating Income (excl Interest) | 726.5K | — | 21.8M | 14.9M | 2.1M |
| EBT (Pre-Tax Income) | (15.5M) | (15.3M) | (34.3M) | (28.7M) | (27.8M) |
| Income Tax Expense | (447.5K) | (443.1K) | (4.0M) | (2.6M) | (1.2M) |
| Bottom Line | |||||
| Net Income | (13.9M) | (13.7M) | (30.2M) | (26.1M) | (26.6M) |
| Earnings from Cont. Ops | (15.0M) | (14.9M) | (30.2M) | (26.1M) | (26.6M) |
| Earnings from Discont. Ops | 1.2M | 1.1M | — | — | — |
| Bottom Line Net Income | (13.9M) | (13.7M) | (30.2M) | (26.1M) | (26.6M) |
| Per Share | |||||
| Basic EPS | ($0.31) | ($0.30) | ($0.90) | ($1.03) | ($1.07) |
| Diluted EPS | ($0.31) | ($0.30) | ($0.90) | ($1.03) | ($1.07) |
| Revenue Per Share | $0.33 | $0.33 | $0.73 | $0.96 | $0.83 |
| Shares | |||||
| Basic Shares Outstanding | 46.7M | 46.4M | 33.4M | 25.6M | 24.9M |
| Diluted Shares Outstanding | 46.7M | 46.4M | 33.4M | 25.6M | 24.9M |
| Profitability Metrics | |||||
| EBITDA | (13.9M) | (13.1M) | (28.9M) | (22.9M) | (21.0M) |
| D&A | 1.6M | 1.6M | 5.1M | 5.7M | 6.7M |
| EBIT | (15.5M) | (14.7M) | (34.0M) | (28.7M) | (27.7M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Apr 1, 2026